Close
Smartlab Europe
Achema middle east

Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?

Asia-Pacific’s biotechnology landscape is not just growing it is...

Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.
- Advertisement -

Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners.

Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging, to protect their products from moisture and oxygen; this includes customizable, high-quality drop-in products (canisters and packets), integrated desiccant systems and specially designed plastic bottles containing oxygen barrier materials. The business has manufacturing facilities in the USA, France, China and India and employs around 700 people. This aligns well with Colorcon’s portfolio and its purpose to improve health and wellness through convenience, compliance and safety.

“Airnov’s capabilities are a strong complement to Colorcon’s existing portfolio” said Simon Tasker, CEO of Colorcon. “Our partnership expands our platform of stability and moisture management solutions from core to coatings to in-package offerings.”

Matthias Brommer, President and Managing Director, Airnov says “We are excited about the opportunity to further accelerate the growth of Airnov by leveraging Colorcon’s global supply and service infrastructure.”

Simon Tasker adds “This acquisition reflects Colorcon’s goal to invest in innovative solutions that help developers of health and wellness products increase speed to market, improve quality and enhance their competitiveness.”

 

Latest stories

Related stories

How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?

Asia-Pacific’s biotechnology landscape is not just growing it is...

Cold Chain and Temperature-Controlled Laboratory Equipment in Pharmaceutical Research and Development

Temperature-sensitive biologics, advanced therapeutics, and pharmaceutical research materials demand specialized cold storage infrastructure spanning ultra-low temperature freezers, controlled-rate freezing systems, and validated stability chambers that maintain precise thermal conditions throughout research, development and testing workflows.

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Smart Laboratories and the Rise of Connected Pharma Equipment Ecosystems

Connected equipment ecosystems revolutionize pharmaceutical operations by integrating AI-driven analytics, digital twins, and seamless middleware to enhance visibility, collaboration, and decision-making across the value chain.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »